Download PDF
Semin Respir Crit Care Med 2021; 42(03): 460-470
DOI: 10.1055/s-0041-1727250
Review Article

Mycobacteria: Selection of Transplant Candidates and Post–lung Transplant Outcomes

Daniel Z.P. Friedman
1   Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
2   Division of Infectious Disease, Department of Medicine, Mayo Clinic, Rochester, Minnesota
,
Karen Doucette
1   Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

Mycobacterium is a large, clinically relevant bacterial genus made up of the agents of tuberculosis and leprosy and hundreds of species of saprophytic nontuberculous mycobacteria (NTM). Pathogenicity, clinical presentation, epidemiology, and antimicrobial susceptibilities are exceptionally diverse between species. Patients with end-stage lung disease and recipients of lung transplants are at a higher risk of developing NTM colonization and disease and of severe manifestations and outcomes of tuberculosis. Data from the past three decades have increased our knowledge of these infections in lung transplant recipients. Still, there are knowledge gaps to be addressed to further our understanding of risk factors and optimal treatments for mycobacterial infections in this population.

Keywords

tuberculosis - leprosy - nontuberculous mycobacteria - Mycobacterium abscessus - Mycobacterium chelonae - Mycobacterium avium complex


Publication History

Article published online:
24 May 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Meyer KC. Recent advances in lung transplantation. F1000 Res 2018; 7: 1684
    CrossrefPubMedGoogle Scholar
  • 2 World Health Organization. Global Tuberculosis Report 2020. 2020 . Accessed January 4, 2021 at: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdf
    PubMedGoogle Scholar
  • 3 Morris MI, Daly JS, Blumberg E. et al. Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report. Am J Transplant 2012; 12 (09) 2288-2300
    CrossrefPubMedGoogle Scholar
  • 4 Brode SK, Daley CL, Marras TK. The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review. Int J Tuberc Lung Dis 2014; 18 (11) 1370-1377
    CrossrefPubMedGoogle Scholar
  • 5 Tissot A, Thomas MF, Corris PA, Brodlie M. Nontuberculous mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice. BMC Pulm Med 2018; 18 (01) 86
    CrossrefPubMedGoogle Scholar
  • 6 Forbes BA, Hall GS, Miller MB. et al. Practical guidance for clinical microbiology laboratories: mycobacteria. Clin Microbiol Rev 2018; 31 (02) e00038-e17
    CrossrefPubMedGoogle Scholar
  • 7 Martinez L, Verma R, Croda J. et al. Detection, survival and infectious potential of Mycobacterium tuberculosis in the environment: a review of the evidence and epidemiological implications. Eur Respir J 2019; 53 (06) 1802302
    CrossrefPubMedGoogle Scholar
  • 8 Velayati AA, Farnia P, Mozafari M. et al. Identification and genotyping of Mycobacterium tuberculosis isolated from water and soil samples of a metropolitan city. Chest 2015; 147 (04) 1094-1102
    CrossrefPubMedGoogle Scholar
  • 9 Rojas-Espinosa O, Løvik M. Mycobacterium leprae and Mycobacterium lepraemurium infections in domestic and wild animals. Rev Sci Tech 2001; 20 (01) 219-251
    CrossrefPubMedGoogle Scholar
  • 10 Daley CL, Iaccarino JM, Lange C. et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline: executive summary. Clin Infect Dis 2020; 71 (04) e1-e36
    CrossrefPubMedGoogle Scholar
  • 11 Koh W-J. Nontuberculous mycobacteria—overview. Microbiol Spectr 2017; 5 (01) 1-7
    CrossrefPubMedGoogle Scholar
  • 12 Vande Weygaerde Y, Cardinaels N, Bomans P. et al. Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis. BMC Infect Dis 2019; 19 (01) 1061
    CrossrefPubMedGoogle Scholar
  • 13 Degiacomi G, Sammartino JC, Chiarelli LR, Riabova O, Makarov V, Pasca MR. Mycobacterium abscessus, an emerging and worrisome pathogen among cystic fibrosis patients. Int J Mol Sci 2019; 20 (23) E5868
    CrossrefPubMedGoogle Scholar
  • 14 Roux A-L, Viljoen A, Bah A. et al. The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages. Open Biol 2016; 6 (11) 160185
    CrossrefPubMedGoogle Scholar
  • 15 Jönsson BE, Gilljam M, Lindblad A, Ridell M, Wold AE, Welinder-Olsson C. Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J Clin Microbiol 2007; 45 (05) 1497-1504
    CrossrefPubMedGoogle Scholar
  • 16 Faria S, Joao I, Jordao L. General overview on nontuberculous mycobacteria, biofilms, and human infection. J Pathogens 2015; 2015: 809014
    CrossrefPubMedGoogle Scholar
  • 17 Torre-Cisneros J, Doblas A, Aguado JM. et al; Spanish Network for Research in Infectious Diseases. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 2009; 48 (12) 1657-1665
    CrossrefPubMedGoogle Scholar
  • 18 Mamishi S, Pourakbari B, Moradzadeh M, van Leeuwen WB, Mahmoudi S. Prevalence of active tuberculosis infection in transplant recipients: a systematic review and meta-analysis. Microb Pathog 2020; 139: 103894
    CrossrefPubMedGoogle Scholar
  • 19 Subramanian AK, Theodoropoulos NM. Infectious Diseases Community of Practice of the American Society of Transplantation. Mycobacterium tuberculosis infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American Society of Transplantation. Clin Transplant 2019; 33 (09) e13513
    CrossrefPubMedGoogle Scholar
  • 20 Hadaya K, Bridevaux P-O, Roux-Lombard P. et al. Contribution of interferon-γ release assays (IGRAs) to the diagnosis of latent tuberculosis infection after renal transplantation. Transplantation 2013; 95 (12) 1485-1490
    CrossrefPubMedGoogle Scholar
  • 21 Horne DJ, Narita M, Spitters CL, Parimi S, Dodson S, Limaye AP. Challenging issues in tuberculosis in solid organ transplantation. Clin Infect Dis 2013; 57 (10) 1473-1482
    CrossrefPubMedGoogle Scholar
  • 22 Sidhu A, Verma G, Humar A, Kumar D. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period. Transplantation 2014; 98 (06) 671-675
    CrossrefPubMedGoogle Scholar
  • 23 Subramanian AK. Tuberculosis in solid organ transplant candidates and recipients: current and future challenges. Curr Opin Infect Dis 2014; 27 (04) 316-321
    CrossrefPubMedGoogle Scholar
  • 24 Tabarsi P, Yousefzadeh A, Najafizadeh K. et al. Performance of QuantiFERON TB Gold test in detecting latent tuberculosis infection in brain-dead organ donors in Iran: a brief report. Saudi J Kidney Dis Transpl 2014; 25 (06) 1240-1243
    CrossrefPubMedGoogle Scholar
  • 25 Jensen TO, Darley DR, Goeman EE, Shaw K, Marriott DJ, Glanville AR. Donor-derived tuberculosis (TB): isoniazid-resistant TB transmitted from a lung transplant donor with inadequately treated latent infection. Transpl Infect Dis 2016; 18 (05) 782-784
    CrossrefPubMedGoogle Scholar
  • 26 Abad CLR, Razonable RR. Donor derived Mycobacterium tuberculosis infection after solid-organ transplantation: a comprehensive review. Transpl Infect Dis 2018; 20 (05) e12971
    CrossrefPubMedGoogle Scholar
  • 27 Kumar D, Budev M, Koval C, Hellinger WC, Gordon SM, Tomford JW. Donor-derived tuberculosis (TB) infection in lung transplant despite following recommended algorithm. Am J Transplant 2013; 13 (08) 2225-2226
    CrossrefPubMedGoogle Scholar
  • 28 Ridgeway AL, Warner GS, Phillips P. et al. Transmission of Mycobacterium tuberculosis to recipients of single lung transplants from the same donor. Am J Respir Crit Care Med 1996; 153 (03) 1166-1168
    CrossrefPubMedGoogle Scholar
  • 29 Weill D, Benden C, Corris PA. et al. A consensus document for the selection of lung transplant candidates: 2014—an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2015; 34 (01) 1-15
    CrossrefPubMedGoogle Scholar
  • 30 Torre-Cisneros J, Castón JJ, Moreno J. et al. Tuberculosis in the transplant candidate: importance of early diagnosis and treatment. Transplantation 2004; 77 (09) 1376-1380
    CrossrefPubMedGoogle Scholar
  • 31 Abad CLR, Razonable RR. Mycobacterium tuberculosis after solid organ transplantation: a review of more than 2000 cases. Clin Transplant 2018; 32 (06) e13259
    CrossrefPubMedGoogle Scholar
  • 32 Bodro M, Sabé N, Santín M. et al. Clinical features and outcomes of tuberculosis in solid organ transplant recipients. Transplant Proc 2012; 44 (09) 2686-2689
    CrossrefPubMedGoogle Scholar
  • 33 Guirao-Arrabal E, Santos F, Redel-Montero J. et al. Risk of tuberculosis after lung transplantation: the value of pretransplant chest computed tomography and the impact of mTOR inhibitors and azathioprine use. Transpl Infect Dis 2016; 18 (04) 512-519
    CrossrefPubMedGoogle Scholar
  • 34 Menzies D, Elwood K. Canadian Tuberculosis Standards: Treatment of Tuberculosis Disease. 7th ed.. Public Health Agency of Canada; 2014
    Google Scholar
  • 35 Nahid P, Dorman SE, Alipanah N. et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis 2016; 63 (07) e147-e195
    CrossrefPubMedGoogle Scholar
  • 36 Solé A, Part-Lopez M, Saez B. et al. Tuberculosis following lung transplantation. A 27-year Spanish Multicenter Experience. Incidence, presentation, prevention and treatment with rifampicin. Arch Bronconeumol 2020; 56 (08) 493-498
    CrossrefPubMedGoogle Scholar
  • 37 Morales P, Briones A, Torres JJ, Solé A, Pérez D, Pastor A. Pulmonary tuberculosis in lung and heart-lung transplantation: fifteen years of experience in a single center in Spain. Transplant Proc 2005; 37 (09) 4050-4055
    CrossrefPubMedGoogle Scholar
  • 38 Gomila-Grange A, Pérez-Recio S, Camprubí-Ferrer D. et al. Rifabutin for treating tuberculosis in solid organ transplant recipients: a retrospective observational study and literature review. Transpl Infect Dis 2020; e13471
    PubMedGoogle Scholar
  • 39 Tabarsi P, Farshidpour M, Marjani M. et al. Mycobacterial infection and the impact of rifabutin treatment in organ transplant recipients: a single-center study. Saudi J Kidney Dis Transpl 2015; 26 (01) 6-11
    CrossrefPubMedGoogle Scholar
  • 40 Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med 2015; 36 (01) 13-34
    CrossrefPubMedGoogle Scholar
  • 41 Zweijpfenning SMH, Ingen JV, Hoefsloot W. Geographic distribution of nontuberculous mycobacteria isolated from clinical specimens: a systematic review. Semin Respir Crit Care Med 2018; 39 (03) 336-342
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Hoefsloot W, van Ingen J, Andrejak C. et al; Nontuberculous Mycobacteria Network European Trials Group. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J 2013; 42 (06) 1604-1613
    CrossrefPubMedGoogle Scholar
  • 43 Spaulding AB, Lai YL, Zelazny AM. et al. Geographic distribution of nontuberculous mycobacterial species identified among clinical isolates in the United States, 2009–2013. Ann Am Thorac Soc 2017; 14 (11) 1655-1661
    CrossrefPubMedGoogle Scholar
  • 44 Al Houqani M, Jamieson F, Chedore P, Mehta M, May K, Marras TK. Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario in 2007. Can Respir J 2011; 18 (01) 19-24
    CrossrefPubMedGoogle Scholar
  • 45 Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax 2007; 62 (08) 661-666
    CrossrefPubMedGoogle Scholar
  • 46 Marras TK, Mendelson D, Marchand-Austin A, May K, Jamieson FB. Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis 2013; 19 (11) 1889-1891
    CrossrefPubMedGoogle Scholar
  • 47 Marras TK, Campitelli MA, Lu H. et al. Pulmonary nontuberculous mycobacteria–associated deaths, Ontario, Canada, 2001–2013. Emerg Infect Dis 2017; 23 (03) 468-476
    CrossrefPubMedGoogle Scholar
  • 48 Griffith DE, Aksamit T, Brown-Elliott BA. et al; ATS Mycobacterial Diseases Subcommittee, American Thoracic Society, Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175 (04) 367-416
    CrossrefPubMedGoogle Scholar
  • 49 Mirsaeidi M, Machado RF, Garcia JGN, Schraufnagel DE. Nontuberculous mycobacterial disease mortality in the United States, 1999–2010: a population-based comparative study. PLoS ONE 2014; 9 (03) e91879
    CrossrefPubMedGoogle Scholar
  • 50 Shah NM, Davidson JA, Anderson LF. et al. Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012. BMC Infect Dis 2016; 16 (01) 195
    CrossrefPubMedGoogle Scholar
  • 51 Thomson RM. NTM working group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis 2010; 16 (10) 1576-1583
    CrossrefPubMedGoogle Scholar
  • 52 Aubry A, Mougari F, Reibel F, Cambau E. Mycobacterium marinum. Microbiol Spectr 2017; 5 (02) DOI: 10.1128/microbiolspec.TNMI7-0038-2016.
    CrossrefPubMedGoogle Scholar
  • 53 Sander MA, Isaac-Renton JL, Tyrrell GJ. Cutaneous nontuberculous mycobacterial infections in Alberta, Canada: an epidemiologic study and review. J Cutan Med Surg 2018; 22 (05) 479-483
    CrossrefPubMedGoogle Scholar
  • 54 Jabbour SF, Malek AE, Kechichian EG, Tomb RR, Nasr MW. Nontuberculous mycobacterial infections after cosmetic procedures: a systematic review and management algorithm. Dermatol Surg 2020; 46 (01) 116-121
    CrossrefPubMedGoogle Scholar
  • 55 Leto Barone AA, Grzelak MJ, Frost C. et al. Atypical mycobacterial infections after plastic surgery procedures abroad: a multidisciplinary algorithm for diagnosis and treatment. Ann Plast Surg 2020; 84 (03) 257-262
    CrossrefPubMedGoogle Scholar
  • 56 Rao M, Silveira FP. Non-tuberculous mycobacterial infections in thoracic transplant candidates and recipients. Curr Infect Dis Rep 2018; 20 (06) 14
    CrossrefPubMedGoogle Scholar
  • 57 Olivier KN, Weber DJ, Wallace Jr RJ. et al; Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria. I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003; 167 (06) 828-834
    CrossrefPubMedGoogle Scholar
  • 58 Luong M-L, Morrissey O, Husain S. Assessment of infection risks prior to lung transplantation. Curr Opin Infect Dis 2010; 23 (06) 578-583
    CrossrefPubMedGoogle Scholar
  • 59 Bernut A, Nguyen-Chi M, Halloum I, Herrmann J-L, Lutfalla G, Kremer L. Mycobacterium abscessus-induced granuloma formation is strictly dependent on TNF signaling and neutrophil trafficking. PLOS Pathog 2016; 12 (11) e1005986
    CrossrefPubMedGoogle Scholar
  • 60 Bernut A, Dupont C, Ogryzko NV. et al. CFTR protects against Mycobacterium abscessus infection by fine-tuning host oxidative defenses. Cell Rep 2019; 26 (07) 1828-1840.e4
    CrossrefPubMedGoogle Scholar
  • 61 Furukawa BS, Flume PA. Nontuberculous mycobacteria in cystic fibrosis. Semin Respir Crit Care Med 2018; 39 (03) 383-391
    Article in Thieme ConnectPubMedGoogle Scholar
  • 62 Horsburgh Jr CR, Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 1989; 139 (01) 4-7
    CrossrefPubMedGoogle Scholar
  • 63 Henkle E, Winthrop KL. Nontuberculous mycobacteria infections in immunosuppressed hosts. Clin Chest Med 2015; 36 (01) 91-99
    CrossrefPubMedGoogle Scholar
  • 64 Browne SK, Burbelo PD, Chetchotisakd P. et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med 2012; 367 (08) 725-734
    CrossrefPubMedGoogle Scholar
  • 65 Honda JR, Alper S, Bai X, Chan ED. Acquired and genetic host susceptibility factors and microbial pathogenic factors that predispose to nontuberculous mycobacterial infections. Curr Opin Immunol 2018; 54: 66-73
    CrossrefPubMedGoogle Scholar
  • 66 Sax H, Bloemberg G, Hasse B. et al. Prolonged outbreak of Mycobacterium chimaera infection after open-chest heart surgery. Clin Infect Dis 2015; 61 (01) 67-75
    CrossrefPubMedGoogle Scholar
  • 67 Doucette K, Fishman JA. Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 2004; 38 (10) 1428-1439
    CrossrefPubMedGoogle Scholar
  • 68 Keating MR, Daly JS. AST Infectious Diseases Community of Practice. Nontuberculous mycobacterial infections in solid organ transplantation. Am J Transplant 2013; 13 (Suppl. 04) 77-82
    CrossrefPubMedGoogle Scholar
  • 69 Todd JL, Lakey J, Howell D, Reidy M, Zaas D. Portal hypertension and granulomatous liver disease in a lung transplant recipient due to disseminated atypical mycobacterial infection. Am J Transplant 2007; 7 (05) 1300-1303
    CrossrefPubMedGoogle Scholar
  • 70 Longworth SA, Vinnard C, Lee I, Sims KD, Barton TD, Blumberg EA. Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study. Transpl Infect Dis 2014; 16 (01) 76-83
    CrossrefPubMedGoogle Scholar
  • 71 Johnson MM, Odell JA. Nontuberculous mycobacterial pulmonary infections. J Thorac Dis 2014; 6 (03) 210-220
    CrossrefPubMedGoogle Scholar
  • 72 Prince DS, Peterson DD, Steiner RM. et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989; 321 (13) 863-868
    CrossrefPubMedGoogle Scholar
  • 73 Sexton P, Harrison AC. Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 2008; 31 (06) 1322-1333
    CrossrefPubMedGoogle Scholar
  • 74 Dorman S, Subramanian A. AST Infectious Diseases Community of Practice. Nontuberculous mycobacteria in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl. 04) S63-S69
    CrossrefPubMedGoogle Scholar
  • 75 Patel R, Roberts GD, Keating MR, Paya CV. Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis 1994; 19 (02) 263-273
    CrossrefPubMedGoogle Scholar
  • 76 Abad CL, Razonable RR. Non-tuberculous mycobacterial infections in solid organ transplant recipients: an update. J Clin Tuberc Other Mycobact Dis 2016; 4: 1-8
    CrossrefPubMedGoogle Scholar
  • 77 Haworth CS, Banks J, Capstick T. et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax 2017; 72 (Suppl. 02) ii1-ii64
    CrossrefPubMedGoogle Scholar
  • 78 Longworth SA, Daly JS. AST Infectious Diseases Community of Practice. Management of infections due to nontuberculous mycobacteria in solid organ transplant recipients—guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33 (09) e13588
    CrossrefPubMedGoogle Scholar
  • 79 Paterson DL, Singh N. Interactions between tacrolimus and antimicrobial agents. Clin Infect Dis 1997; 25 (06) 1430-1440
    CrossrefPubMedGoogle Scholar
  • 80 De La Cruz O, Minces LR, Silveira FP. Experience with linezolid for the treatment of nocardiosis in organ transplant recipients. J Infect 2015; 70 (01) 44-51
    CrossrefPubMedGoogle Scholar
  • 81 Tessier JM, Puzio T, Young A, Wolfe L, Han J, Duane TM. Thrombocytopenia associated with linezolid therapy in solid organ transplant recipients: a retrospective cohort study. Surg Infect (Larchmt) 2015; 16 (04) 361-367
    CrossrefPubMedGoogle Scholar
  • 82 Bidell MR, Lodise TP. Fluoroquinolone-associated tendinopathy: Does levofloxacin pose the greatest risk?. Pharmacotherapy 2016; 36 (06) 679-693
    CrossrefPubMedGoogle Scholar
  • 83 Anjan S, Morris MI. How can we improve the outcome for transplant patients with nontuberculous mycobacterial infections?. Future Microbiol 2018; 13 (08) 903-914
    CrossrefPubMedGoogle Scholar
  • 84 Aslam S. Bacteriophage therapy as a treatment option for transplant infections. Curr Opin Infect Dis 2020; 33 (04) 298-303
    CrossrefPubMedGoogle Scholar
  • 85 Aslam S, Courtwright AM, Koval C. et al. Early clinical experience of bacteriophage therapy in 3 lung transplant recipients. Am J Transplant 2019; 19 (09) 2631-2639
    CrossrefPubMedGoogle Scholar
  • 86 Dedrick RM, Guerrero-Bustamante CA, Garlena RA. et al. Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus. Nat Med 2019; 25 (05) 730-733
    CrossrefPubMedGoogle Scholar
  • 87 Fox A. Engineered phages stymie drug-resistant infection. Science 2019; 364 (6440): 518-519
    CrossrefPubMedGoogle Scholar
  • 88 Weill D. Lung transplantation: indications and contraindications. J Thorac Dis 2018; 10 (07) 4574-4587
    CrossrefPubMedGoogle Scholar
  • 89 Friedman DZP, Cervera C, Halloran K, Tyrrell G, Doucette K. Non-tuberculous mycobacteria in lung transplant recipients: prevalence, risk factors, and impact on survival and chronic lung allograft dysfunction. Transpl Infect Dis 2020; 22 (02) e13229
    CrossrefPubMedGoogle Scholar
  • 90 Hamad Y, Pilewski JM, Morrell M, D'Cunha J, Kwak EJ. Outcomes in lung transplant recipients with Mycobacterium abscessus infection: a 15-year experience from a large tertiary care center. Transplant Proc 2019; 51 (06) 2035-2042
    CrossrefPubMedGoogle Scholar
  • 91 Longworth SA, Blumberg EA, Barton TD, Vinnard C. Non-tuberculous mycobacterial infections after solid organ transplantation: a survival analysis. Clin Microbiol Infect 2015; 21 (01) 43-47
    CrossrefPubMedGoogle Scholar
  • 92 Huang HC, Weigt SS, Derhovanessian A. et al. Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality. J Heart Lung Transplant 2011; 30 (07) 790-798
    CrossrefPubMedGoogle Scholar
  • 93 Knoll BM, Kappagoda S, Gill RR. et al. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study. Transpl Infect Dis 2012; 14 (05) 452-460
    CrossrefPubMedGoogle Scholar
  • 94 George IA, Santos CAQ, Olsen MA, Bailey TC. Epidemiology and outcomes of nontuberculous mycobacterial infections in solid organ transplant recipients at a Midwestern center. Transplantation 2016; 100 (05) 1073-1078
    CrossrefPubMedGoogle Scholar
  • 95 Shah SK, McAnally KJ, Seoane L. et al. Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation. Transpl Infect Dis 2016; 18 (04) 585-591
    CrossrefPubMedGoogle Scholar
  • 96 Hirama T, Singer LG, Brode SK, Marras TK, Husain S. Outcomes of a peri- and postoperative management protocol for non-TB mycobacteria in lung transplant recipients. Chest 2020; 158 (02) 523-528
    CrossrefPubMedGoogle Scholar
  • 97 Kabbani D, Kozlowski HN, Cervera C. et al. Granuloma in the explanted lungs: Infectious causes and impact on post-lung transplant mycobacterial infection. Transpl Infect Dis 2020; 22 (03) e13262
    CrossrefPubMedGoogle Scholar
  • 98 Watkins RR, Lemonovich TL. Evaluation of infections in the lung transplant patient. Curr Opin Infect Dis 2012; 25 (02) 193-198
    CrossrefPubMedGoogle Scholar
  • 99 Taylor JL, Palmer SM. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. J Heart Lung Transplant 2006; 25 (08) 985-988
    CrossrefPubMedGoogle Scholar
  • 100 Chernenko SM, Humar A, Hutcheon M. et al. Mycobacterium abscessus infections in lung transplant recipients: the international experience. J Heart Lung Transplant 2006; 25 (12) 1447-1455
    CrossrefPubMedGoogle Scholar
  • 101 Zaidi S, Elidemir O, Heinle JS. et al. Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence. Transpl Infect Dis 2009; 11 (03) 243-248
    CrossrefPubMedGoogle Scholar
  • 102 Perez AA, Singer JP, Schwartz BS. et al. Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: a single center experience. Transpl Infect Dis 2019; 21 (03) e13084
    CrossrefPubMedGoogle Scholar
  • 103 Brown-Elliott BA, Wallace Jr RJ. Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002; 15 (04) 716-746
    CrossrefPubMedGoogle Scholar
  • 104 Trulock EP, Bolman RM, Genton R. Pulmonary disease caused by Mycobacterium chelonae in a heart-lung transplant recipient with obliterative bronchiolitis. Am Rev Respir Dis 1989; 140 (03) 802-805
    CrossrefPubMedGoogle Scholar
  • 105 Swetter SM, Kindel SE, Smoller BR. Cutaneous nodules of Mycobacterium chelonae in an immunosuppressed patient with preexisting pulmonary colonization. J Am Acad Dermatol 1993; 28 (2, Pt 2): 352-355
    CrossrefPubMedGoogle Scholar
  • 106 Baisi A, Nosotti M, Chella B, Santambrogio L. Relapsing cutaneous Mycobacterium chelonae infection in a lung transplant patient. Transpl Int 2005; 18 (09) 1117-1119
    CrossrefPubMedGoogle Scholar
  • 107 Ambaraghassi G, Ferraro P, Poirier C, Rouleau D, Fortin C. Double lung transplantation in an HIV-positive patient with Mycobacterium kansasii infection. Transpl Infect Dis 2019; 21 (01) e12999
    CrossrefPubMedGoogle Scholar
  • 108 Malouf MA, Glanville AR. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med 1999; 160 (5, Pt 1): 1611-1616
    CrossrefPubMedGoogle Scholar
  • 109 Ariza-Heredia EJ, Dababneh AS, Wilhelm MP, Wengenack NL, Razonable RR, Wilson JW. Mycobacterium wolinskyi: a case series and review of the literature. Diagn Microbiol Infect Dis 2011; 71 (04) 421-427
    CrossrefPubMedGoogle Scholar
  • 110 Date A, John GT, Thomas PP, Jacob CK. Leprosy and renal transplantation. Lepr Rev 1998; 69 (01) 40-45
    PubMedGoogle Scholar
  • 111 Guditi S, Ram R, Ismal KM. et al. Leprosy in a renal transplant recipient: review of the literature. Transpl Infect Dis 2009; 11 (06) 557-562
    CrossrefPubMedGoogle Scholar
  • 112 Modi K, Mancini M, Joyce MP. Lepromatous leprosy in a heart transplant recipient. Am J Transplant 2003; 3 (12) 1600-1603
    CrossrefPubMedGoogle Scholar
  • 113 Gasink LB, Seymour C, Blumberg EA, Goldberg LR, Fishman NO. An uncommon presentation of an uncommon disease: leprosy in a heart transplant recipient. J Heart Lung Transplant 2006; 25 (07) 854-856
    CrossrefPubMedGoogle Scholar
  • 114 World Health Organization. Guidelines for the Diagnosis, Treatment and Prevention of Leprosy. Published online 2018. Accessed March 5, 2021 at: https://www.who.int/lep/resources/9789290226383/en/
    PubMedGoogle Scholar
  • 115 Finch CK, Chrisman CR, Baciewicz AM, Self TH. Rifampin and rifabutin: an update. Arch Intern Med 2002; 162: 985-992
    CrossrefPubMedGoogle Scholar
  • 116 Sparkes T, Lemonovich TL. AST Infectious Diseases Community of Practice. Interactions between anti-infective agents and immunosuppressants—Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 2019; 33 (09) e13510
    CrossrefPubMedGoogle Scholar
  • 117 Hernández-Garduño E, Rodrigues M, Elwood RK. The incidence of pulmonary non-tuberculous mycobacteria in British Columbia, Canada. Int J Tuberc Lung Dis 2009; 13 (09) 1086-1093
    PubMedGoogle Scholar
  • 118 Bodle EE, Cunningham JA, Della-Latta P, Schluger NW, Saiman L. Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis 2008; 14 (03) 390-396
    CrossrefPubMedGoogle Scholar
  • 119 Prevots DR, Shaw PA, Strickland D. et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010; 182 (07) 970-976
    CrossrefPubMedGoogle Scholar
  • 120 Smith GS, Ghio AJ, Stout JE. et al. Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents, 2006-2010. J Infect 2016; 72 (06) 678-686
    CrossrefPubMedGoogle Scholar
  • 121 Henkle E, Hedberg K, Schafer S, Novosad S, Winthrop KL. Population-based Incidence of pulmonary nontuberculous mycobacterial disease in Oregon 2007 to 2012. Ann Am Thorac Soc 2015; 12 (05) 642-647
    CrossrefPubMedGoogle Scholar
  • 122 Winthrop KL, McNelley E, Kendall B. et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010; 182 (07) 977-982
    CrossrefPubMedGoogle Scholar
  • 123 Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL. Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 2009; 49 (12) e124-e129
    CrossrefPubMedGoogle Scholar
  • 124 Novosad SA, Henkle E, Schafer S. et al. Mortality after respiratory isolation of nontuberculous mycobacteria: a comparison of patients who did and did not meet disease criteria. Ann Am Thorac Soc 2017; 14 (07) 1112-1119
    PubMedGoogle Scholar
  • 125 Adjemian J, Frankland TB, Daida YG. et al. Epidemiology of nontuberculous mycobacterial lung disease and tuberculosis, Hawaii, USA. Emerg Infect Dis 2017; 23 (03) 439-447
    CrossrefPubMedGoogle Scholar